DE69929387D1 - Pharmazeutische Zusammensetzungen zur oralen Verabreichung, die einen magensaftresistenten Überzug auf der Basis von Acrylatpolymeren enthalten - Google Patents
Pharmazeutische Zusammensetzungen zur oralen Verabreichung, die einen magensaftresistenten Überzug auf der Basis von Acrylatpolymeren enthaltenInfo
- Publication number
- DE69929387D1 DE69929387D1 DE69929387T DE69929387T DE69929387D1 DE 69929387 D1 DE69929387 D1 DE 69929387D1 DE 69929387 T DE69929387 T DE 69929387T DE 69929387 T DE69929387 T DE 69929387T DE 69929387 D1 DE69929387 D1 DE 69929387D1
- Authority
- DE
- Germany
- Prior art keywords
- pharmaceutical compositions
- oral administration
- enteric coating
- active ingredient
- acrylate polymers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000002702 enteric coating Substances 0.000 title 1
- 238000009505 enteric coating Methods 0.000 title 1
- 229920000058 polyacrylate Polymers 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 3
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 abstract 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 abstract 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 208000028774 intestinal disease Diseases 0.000 abstract 1
- 210000000936 intestine Anatomy 0.000 abstract 1
- 230000000622 irritating effect Effects 0.000 abstract 1
- KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 abstract 1
- 229960004963 mesalazine Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920001897 terpolymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/606—Salicylic acid; Derivatives thereof having amino groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1998MI002467A IT1303753B1 (it) | 1998-11-13 | 1998-11-13 | Composizioni farmaceutiche somministrabili per via orale contenentiun rivestimento gastroresistente a base di polimeri acrilici. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE69929387D1 true DE69929387D1 (de) | 2006-04-06 |
Family
ID=11381056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69929387T Expired - Lifetime DE69929387D1 (de) | 1998-11-13 | 1999-11-11 | Pharmazeutische Zusammensetzungen zur oralen Verabreichung, die einen magensaftresistenten Überzug auf der Basis von Acrylatpolymeren enthalten |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1004297B1 (de) |
| AT (1) | ATE315382T1 (de) |
| DE (1) | DE69929387D1 (de) |
| IT (1) | IT1303753B1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10013030A1 (de) * | 2000-03-17 | 2001-09-20 | Roehm Gmbh | Verwendung eines Copolymers zur Herstellung einer Arzneiform zur Therapie von Colitis ulcerosa und verwendungsgemäße Arzneiform |
| AR036797A1 (es) * | 2001-10-15 | 2004-10-06 | Ferring Bv | Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn |
| IL161193A0 (en) * | 2001-10-15 | 2004-08-31 | Ferring Bv | Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease |
| BG65471B1 (bg) * | 2002-04-02 | 2008-09-30 | "Софарма" Ад | Лекарствена форма на мезалазин и метод за нейнотополучаване |
| CA2520197A1 (en) | 2003-04-23 | 2004-11-04 | Ferring B.V. | Sachet for a pharmaceutical composition |
| ITMI20032087A1 (it) * | 2003-10-27 | 2005-04-28 | Pharmafilm S R L | Film autosupportanti per uso farmaceutico ed alimentare. |
| ITUB20160203A1 (it) * | 2016-01-19 | 2017-07-19 | Valpharma Int Spa | Formulazioni in compresse a rilascio modificato contenenti Mesalazina ad alto dosaggio, processo per la loro preparazione e loro uso. |
| ITUA20162293A1 (it) * | 2016-04-05 | 2017-10-05 | Sofar Spa | Processo per formulazioni solide di mesalazina |
| IT201800005908A1 (it) * | 2018-05-31 | 2019-12-01 | Compressa gastroresistente rivestita con film per il rilascio protratto di acido butirrico |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA825384B (en) * | 1981-07-31 | 1983-05-25 | Tillott J B Ltd | Orally administrable pharmaceutical compositions |
| DE9414066U1 (de) * | 1994-08-31 | 1994-11-03 | Röhm GmbH & Co. KG, 64293 Darmstadt | Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform |
-
1998
- 1998-11-13 IT IT1998MI002467A patent/IT1303753B1/it active
-
1999
- 1999-11-11 DE DE69929387T patent/DE69929387D1/de not_active Expired - Lifetime
- 1999-11-11 AT AT99122470T patent/ATE315382T1/de not_active IP Right Cessation
- 1999-11-11 EP EP99122470A patent/EP1004297B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1004297A1 (de) | 2000-05-31 |
| ITMI982467A1 (it) | 2000-05-13 |
| ATE315382T1 (de) | 2006-02-15 |
| EP1004297B1 (de) | 2006-01-11 |
| IT1303753B1 (it) | 2001-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE30380T1 (de) | Pharmazeutische formulierungen mit mehrfachen einheiten. | |
| NZ503946A (en) | Oral dosage form in an oval or caplet shape for administration of bisphosphonates and other known medicaments | |
| MX9804008A (es) | Formulaciones farmaceuticas. | |
| SE9301489D0 (sv) | Veterinary composition | |
| ATE129893T1 (de) | Orale dosierungsform mit verzögerter wirkstoffabgabe für die behandlung von intestinalen krankheiten. | |
| ATE217188T1 (de) | Granulierte pharmazeutische zusammensetzung | |
| ATE208192T1 (de) | Formulierungen mit gesteuerter freisetzung für schwerlösliche arzneistoffe | |
| WO2006102446A3 (en) | Multi-particulate, modified-released colonic composition | |
| DK0825858T3 (da) | Flerumættede omega-3-fedtsyrer til behandling af inflammatorisk tarmsygdom i kapsler med tidsafhængig frigivelse | |
| ATE260648T1 (de) | Überzugs- und bindemittel für arzneiformen sowie damit hergestellte arzneiform | |
| NO20020939L (no) | Oral administreringsform | |
| EP0136103B1 (de) | Amosulalolhydrochlorid-Formulierungen mit lang anhaltender Wirkung | |
| CY1108863T1 (el) | Φαρμακευτικο σκευασμα εκτεταμενης απελευθερωσης ανεξαρτητης απο το ρη | |
| DE69929387D1 (de) | Pharmazeutische Zusammensetzungen zur oralen Verabreichung, die einen magensaftresistenten Überzug auf der Basis von Acrylatpolymeren enthalten | |
| CA2219777A1 (en) | Nanoparticles for oral administration of pharmaceutical agents of low solubility | |
| DZ2316A1 (fr) | Micro sphères pharmaceutiques d'acide valproique pour administration orale. | |
| DE60006362D1 (de) | Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen | |
| PL327323A1 (en) | Orally administered 5-asa containing pharmaceutic composition of modified active substance release and method of treating intestinal diseases | |
| BE880648A (fr) | Nouvelles formes galeniques d'administration de medicaments par voie orale, aliberation programmee et leurs procedes de preparation | |
| TH17624A (th) | สูตรผสมทางสัตวแพทย์ | |
| CA2161683A1 (en) | Veterinary composition containing a proton pump inhibitor | |
| CO4910116A1 (es) | Formulacion de liberacion controlada para farmacos basicos escasamente solubles | |
| TH27939B (th) | สูตรส่วนผสมทางเภสัช | |
| IT1254688B (it) | Composizioni farmaceutiche somministrabili per via orale a rilascio mirato contenenti acido ursodesossicolico ed acido chenodesossicolico. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8332 | No legal effect for de |